
Sign up to save your podcasts
Or


This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.
By Sharesies5
33 ratings
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.

16,184 Listeners

20 Listeners

8,847 Listeners

3,952 Listeners

65 Listeners

371 Listeners

27 Listeners

130 Listeners

610 Listeners

15 Listeners

12 Listeners

86 Listeners

2,153 Listeners

600 Listeners

15 Listeners